Research News
DORIS DUKE CHARITABLE FOUNDATION (DDCF) – CLINICAL SCIENTIST DEVELOPMENT AWARD
Purpose: Physician scientists pursuing research careers face challenges that are particular to their dual roles as researchers and health care providers. The purpose of the Doris Duke Clinical Scientist Development…
Purpose: The American Diabetes Association (ADA), through support provided by Pfizer, Inc., is now requesting applications for postdoctoral fellows proposing basic, clinical and translational research focused on cardiovascular disease in…
Purpose: The purpose of this funding opportunity announcement (FOA) is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of…
Purpose: This Funding Opportunity Announcement (FOA) invites applications for centers to support transdisciplinary teams of clinical and mental health services researchers, behavioral scientists, social scientists, health information and communications technologists,…
Purpose: The Institutional Research and Academic Career Development Award (IRACDA) Program provides support for a mentored postdoctoral research experience at a research-intensive institution combined with an opportunity to develop critical…
Purpose: The NIH Blueprint for Neuroscience Research is a collaborative framework through which 14 NIH Institutes, Centers and Offices jointly support neuroscience related research, with the aim of accelerating discoveries…
Purpose: This Funding Opportunity Announcement (FOA) invites researchers to submit applications for multidisciplinary diagnostic strategies for rare diseases that combine machine-assistance, genomic analysis, and clinical consultation. Of particular importance, these…
Early-Career Awards: Career Development Award (CDA) in Palliative and Supportive Care in Oncology Grant Amount: $200,000 | Application Deadline: September 24th Career Development Award (CDA) (for all subject areas) Grant…
Purpose: The Melanoma Research Alliance (MRA) is pleased to announce a Second Release of its Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to…
Purpose: This Funding Opportunity Announcement (FOA) invites R18 grant applications that disseminate and implement patient-centered outcomes research (PCOR) evidence into clinical practice through clinical decision support (CDS). AHRQ seeks projects…
National Multiple Sclerosis Society – Biostatistics/Informatics Junior Faculty Award
Purpose: As part of our commitment to building a workforce of research leaders to drive pathways to MS cures, the National MS Society established a junior faculty award in biostatistics/…
Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed) (RFA-OD-20-014) National Institutes of Health National Center for Complementary and Integrative Health National Cancer Institute National Institute…
Purpose: The National Institutes of Health (NIH) is issuing this funding opportunity announcement (FOA) in response to the declared public health emergency issued by the Secretary, Department of Health and…
Purpose: The purpose of this urgent funding opportunity announcement is to invite applications to repurpose existing therapeutic agents to treat Coronavirus Disease 2019 (COVID-19) sequelae and associated complications that result…
Purpose: The purpose of this initiative is to support investigator-initiated research on genetic counseling processes and practices in genomic medicine. Research is needed to optimize the genetic counseling process in…
NIH – Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)
Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of devices to treat Substance Use Disorders (SUDs). The continuing advances in technologies offer unprecedented opportunities…Melanoma Research Alliance – pre-clinical, translational, and early clinical research
Purpose: The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact,…
Purpose: Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) along with the National Human Genome Research Institute (NHGRI) and National Institute of Dental and Craniofacial Research (NIDCR)…
Stand Up To Cancer (SU2C) – Health Equity Breakthrough Team Research Grant Program
Purpose: The Breakthrough Team represents an unprecedented opportunity to bring together the best scientific minds from diverse fields of research to concentrate on new approaches to address health equity in…NINDS Exploratory Grant Program in Parkinson’s Disease Research (P20- Clinical Trial Optional)
Purpose: This Funding Opportunity Announcement (FOA) invites Exploratory Grant (P20) applications for the planning and initiation of collaborative efforts to advance Parkinson’s Disease (PD) research. The goal of this program…
Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to support basic and clinical mechanistic research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)…
Purpose: This Funding Opportunity Announcement (FOA) encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations…
Purpose: This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated multi-site clinical trials (all phases or stages) of interventions focused on specific aging-related issues to reducing transmission, risk, morbidity,…
Ovarian Cancer Research Alliance – Multiple Funding Opportunities
Purpose: Ovarian Cancer Research Alliance is the largest global charity funding ovarian cancer research. In the U.S., OCRA is the largest non-government funder of ovarian cancer research. OCRA grant programs…Gateway for Cancer Research – Continuity of patient access to clinical trials during Pandemic
PURPOSE: The oncology community must continue to urgently respond to the significant disruption of clinical trials caused by the COVID-19 pandemic. To that end, Gateway for Cancer Research is committing…